Literature DB >> 12181442

Characterization and comparison of RGS2 and RGS4 as GTPase-activating proteins for m2 muscarinic receptor-stimulated G(i).

Wendy Cladman1, Peter Chidiac.   

Abstract

RGS2 and RGS4 were studied for their effects as GTPase activating proteins (GAPs) on receptor-activated G(i) in a novel steady-state assay using membranes from Sf9 cells quadruply infected with baculoviruses encoding the m2 muscarinic receptor, G(alphai2), G(beta1), and G(gamma2). In the presence of the muscarinic agonist carbachol, regulator of G protein signaling 2 (RGS2) and RGS4 each produced up to a 10-fold increase in agonist-dependent GTPase activity. The observed K(m) for GTP in this system was increased in the presence of RGS4. NaCl and KCl inhibited the GAP activities of both RGS2 and RGS4, although they had no effect on GTPase activity in the absence of RGS proteins. MgCl(2) had a complex effect on GTPase activity, with optimal RGS2 and RGS4 GAP activities occurring, respectively, at high micromolar and low millimolar concentrations of free Mg(2+). The concentration dependence of RGS GAP activity was assessed, and RGS4 was found to be more potent than RGS2 by up to an order of magnitude. This direct observation confirms a similar difference in potency found when these two RGS proteins were compared for their ability to inhibit signaling downstream of G(i). RGS2 yielded Hill coefficients greater than 2.0, suggesting that it may bind in a positively cooperative manner to oligomeric structures containing more than one G protein. Furthermore, RGS4 yielded a bell-shaped dose-dependence under low magnesium (0.5 mM) conditions, which is also consistent with the idea of RGS cooperativity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181442     DOI: 10.1124/mol.62.3.654

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  10 in total

1.  Structural determinants of G-protein alpha subunit selectivity by regulator of G-protein signaling 2 (RGS2).

Authors:  Adam J Kimple; Meera Soundararajan; Stephanie Q Hutsell; Annette K Roos; Daniel J Urban; Vincent Setola; Brenda R S Temple; Bryan L Roth; Stefan Knapp; Francis S Willard; David P Siderovski
Journal:  J Biol Chem       Date:  2009-05-28       Impact factor: 5.157

2.  Structural and functional analysis of the regulator of G protein signaling 2-gαq complex.

Authors:  Mark R Nance; Barry Kreutz; Valerie M Tesmer; Rachel Sterne-Marr; Tohru Kozasa; John J G Tesmer
Journal:  Structure       Date:  2013-02-21       Impact factor: 5.006

3.  Residue-level determinants of RGS R4 subfamily GAP activity and specificity towards the Gi subfamily.

Authors:  Ali Asli; Sabreen Higazy-Mreih; Meirav Avital-Shacham; Mickey Kosloff
Journal:  Cell Mol Life Sci       Date:  2021-07-22       Impact factor: 9.261

Review 4.  Regulators of G-protein signaling in the heart and their potential as therapeutic targets.

Authors:  Peng Zhang; Ulrike Mende
Journal:  Circ Res       Date:  2011-07-22       Impact factor: 17.367

5.  Role of Cholinergic Innervation and RGS2 in Atrial Arrhythmia.

Authors:  Douglas L Jones; Jari M Tuomi; Peter Chidiac
Journal:  Front Physiol       Date:  2012-06-29       Impact factor: 4.566

6.  The Ras-binding domain region of RGS14 regulates its functional interactions with heterotrimeric G proteins.

Authors:  Peishen Zhao; Caroline Nunn; Suneela Ramineni; John R Hepler; Peter Chidiac
Journal:  J Cell Biochem       Date:  2013-06       Impact factor: 4.429

7.  The proline-rich N-terminal domain of G18 exhibits a novel G protein regulatory function.

Authors:  Peishen Zhao; Chau H Nguyen; Peter Chidiac
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

8.  Structural diversity in the RGS domain and its interaction with heterotrimeric G protein alpha-subunits.

Authors:  Meera Soundararajan; Francis S Willard; Adam J Kimple; Andrew P Turnbull; Linda J Ball; Guillaume A Schoch; Carina Gileadi; Oleg Y Fedorov; Elizabeth F Dowler; Victoria A Higman; Stephanie Q Hutsell; Michael Sundström; Declan A Doyle; David P Siderovski
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

Review 9.  Cholinergic activity as a new target in diseases of the heart.

Authors:  Ashbeel Roy; Silvia Guatimosim; Vania F Prado; Robert Gros; Marco A M Prado
Journal:  Mol Med       Date:  2015-01-26       Impact factor: 6.354

Review 10.  Psychostimulants, madness, memory... and RGS proteins?

Authors:  Scott A Burchett
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 4.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.